The portable, easy-to-use BD Veritor™ Plus System for Rapid Antigen Detection of SARS-CoV-2 is a chromatographic digital immunoassay intended for the direct and qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasal swabs from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms. It provides highly reliable COVID-19 (SARS-CoV-2) results you can count on in just 15 minutes.

BD Veritor™ System for Rapid Detection of SARS-CoV-2 has a 98%-100% specificity^*, which means the false positive rate is less than 2% of all tests performed • So when you use your BD Veritor™ System for Rapid Detection of SARS-CoV-2 you might see 0-2 false positives for every 100 tests you conduct

The

FREE online education and training supports understanding of the system